Q3 2015 Results 13 November 2015 Profit & Loss: Key Figures (in - PowerPoint PPT Presentation

Q3 2015 Results 13 November 2015

Profit & Loss: Key Figures (in million Euro) Δ % Δ % Q3'14 Q3'15 9M'14 9M'15 (excl. X-rate) (excl. X-rate) Sales 636 661 3.9% (-2.3%) 1,909 1,974 3.4% (-4.3%) Gross Profit* 196 209 6.6% 585 635 8.5% as a % of sales 30.8% 31.6% 30.6% 32.2% SG&A* -122 -126 3.3% -375 -391 4.3% SG&A as % of sales 19.2% 19.1% 19.6% 19.8% R&D* -37 -36 -2.7% -109 -109 0.0% Other operating items* -3 -3 -5 -6 Recurring EBITDA* 51 60 17.6% 148 175 18.2% as a % of sales 8.0% 9.1% 7.8% 8.9% Recurring EBIT* 34 46 35.3% 96 130 35.4% as a % of sales 5.3% 7.0% 5.0% 6.6% * Before restructuring charges and non-recurring items 2

Profit & Loss: Key Figures (in million Euro) Δ % Δ % Q3'14 Q3'15 9M '14 9M '15 Recurring EBIT* 34 46 35.3% 96 130 35.4% Restructuring and non-recurring -5 -3 -40.0% -8 -15 87.5% Operating result 29 43 48.3% 88 115 30.7% Non-operating result -15 -12 -42 -43 Profit before taxes 14 31 121.4% 46 72 56.5% Taxes -5 2 -8 -11 Net result 9 33 266.7% 38 61 60.5% 6 30 31 55 of which attr to equity holders of the company 3 3 7 6 of which attr to non controlling interests * Before restructuring charges and non-recurring items 3

Net Financial Debt (in million Euro) 434391398 313339 267291306295291337299261217191176175126 94 102 83 161189 Q1'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q210 4

Working Capital: Key Figures (in million Euro/days) Inventories Trade Receivables* Trade Payables 800 800 800 700 700 717 719 700 711 691 688 688 686 648 639 635 600 600 600 597 580 577 575 561 563 544 542 500 500 500 527 512 498 496 487 482 484 476 464 452 452 400 438 400 436 400 421 413 399 388 384 371 363 300 300 300 123 123 121 293 293 287 116 115 113 114 114 278 112 112 275 111 269 267 108 107 260 259 106 257 253 103 10296100 102 239 241 239 239 238 200 200 230 225 225 200 100 100 100 62 52 56 57 56 61 41 45 44 4339 42 41 46 44 46 51 47 47 60 59 60 5653 55 59 46 44 45 47 48 55 55 52 55 54 48 50 0 0 0 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q1 '11 Q2 '11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14 Q3'14 Q4'14 Q1'15 Q2'15 Q3'15 Q1 '11 Q2 '11 1 1 2 2 2 2 3 3 3 3 4 4 4 4 5 5 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 1 2 Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q * Trade receivables minus deferred revenue and advanced payments from customers 5

Main Group Drivers behind Key Figures Q3 2015 • Continued revenue growth • Positive gross margin trend confirmed • Net profit of 33 million Euro • Further decrease in net debt 6

Graphics

Graphics: YTD Sales per Business Segment 9M 2015 100% = 1,008 million Euro Inkjet, Software, Service 21% Analog Prepress 12% Digital Prepress 67% 8

Graphics: Key Figures (in million Euro) Δ % Δ % Q3'14 Q3'15 9M'14 9M'15 (excl. curr.) (excl. curr. ) Sales 328 338 3.0% (-4.2%) 994 1,008 1.4% (-7.3%) Gross Profit* 93 93 0.0% 283 285 0.7% as a % of sales 28.4% 27.5% 28.5% 28.3% SG&A* -65 -64 -1.5% -198 -205 3.5% as % of sales 19.8% 18.9% 19.9% 20.3% R&D* -10 -11 10.0% -31 -34 9.7% Other operating items* -3 -1 -5 -3 Recurring EBITDA* 22.1 24.4 10.4% 71.4 65.8 -7.8% as a % of sales 6.7% 7.2% 7.2% 6.5% Recurring EBIT* 14.7 16.8 14.3% 48.8 43.1 -11.7% as a % of sales 4.5% 5.0% 4.9% 4.3% * Before restructuring charges and non-recurring items 9

Graphics: Main Drivers behind Key Figures Q3 2015 • Agfa Graphics posted revenue growth for the second quarter in a row despite the softness in the emerging markets and the political instability in certain regions • Top line growth was driven by a solid double-digit growth of the inkjet segment, an improving volume trend in the digital prepress and positive currency effects • The analog prepress business continued to decline strongly • The gross profit margin decreased as the efficiency programs were not able to fully offset the adverse raw material and competitive pressure effects • Recurring EBIT at 16.8 million Euro • Business highlights: • Continuous global success of the Jeti and Anapurna inkjet printer ranges • Launch of the next generation chemistry-free printing plate for newspapers: N95-VCF • Launch of a new version of the StoreFront web-to-print workflow system 10

HealthCare

HealthCare: YTD Sales per Business Segment 9M 2015 100% = 824 million Euro Hardcopy 32% Classic Radiology 8% CR/Modalities 20% Imaging IT Solutions* 27% HCIS 13% HealthCare IT = 40% * Includes Radiology and Cardiology IT 12

HealthCare: Key Figures (in million Euro) Δ % Δ % Q3'14 Q3'15 9M'14 9M'15 (excl. curr.) (excl. curr. ) Sales 259 276 6.6% (1.1%) 766 824 7.6% (0.3%) Gross Profit* 93 107 15.1% 276 317 14.9% as a % of sales 35.9% 38.8% 36.0% 38.5% SG&A* -52 -54 3.8% -160 -167 4.4% as % of sales 20.1% 19.6% 20.9% 20.3% R&D* -25 -23 -8.0% -73 -69 -5.5% Other operating items* 1 -2 1 -1 Recurring EBITDA* 26.2 33.9 29.4% 71.2 99.8 40.2% as a % of sales 10.1% 12.3% 9.3% 12.1% Recurring EBIT* 17.6 27.6 56.8% 44.8 79.8 78.1% as a % of sales 6.8% 10.0% 5.8% 9.7% * Before restructuring charges and non-recurring items 13

HealthCare: Main Drivers behind Key Figures Q3 2015 • Partly due to currency effects, solid topline growth for the third consecutive quarter • In the Imaging segment’s digital radiography business, the DR product range continued its strong revenue growth while the hardcopy product range also performed well • In the IT segment, the HealthCare Information Solutions range posted revenue growth. In the field of Imaging IT, HealthCare is making good progress with the rollout of its new Enterprise Imaging Platform • Gross profit margin improved significantly thanks to the efficiency programs • Recurring EBIT at 27.6 million Euro • Business highlights: • Major digital radiography contracts in the US, the UK, Saudi Arabia, Jordan,… • Northwestern Medicine (US) selects Enterprise Imaging for Radiology • Agfa HealthCare becomes a supplier in the Healthcare CIS Framework (UK)

Specialty Products

Specialty Products: Key Figures (in million Euro) Δ % Δ % Q3'14 Q3'15 9M'14 9M'15 (excl. curr.) (excl. curr. ) Sales 49 47 -4.1% (-6.5%) 149 142 -4.7% (-8.2%) Gross Profit* 9 9 0,0% 25 33 32,0% as a % of sales 18,4% 19,1% 16,8% 23,2% SG&A* -6 -5 -16,7% -17 -18 5,9% as % of sales 12,2% -10,6% 11,4% -12,7% R&D* -2 -2 0,0% -5 -6 20,0% Other operating items* 1 1 0,0% 2 2 0,0% Recurring EBITDA* 3,4 3,5 2,9% 8,5 13,8 62,4% as a % of sales 6,9% 7,4% 5,7% 9,7% Recurring EBIT* 2,4 2,5 4,2% 5,2 10,8 107,7% as a % of sales 4,9% 5,3% 3,5% 7,6% * Before restructuring charges and non-recurring items 16

Specialty Products: Main Drivers behind Key Figures Q3 2015 • Revenue decreased to 47 million Euro. • The future-oriented businesses (mainly Synaps Synthetic Paper and Orgacon Electronic Materials) as well as the PCB business performed well and partly counterbalanced the decline of the traditional film businesses • Recurring EBIT at 2.5 million Euro • Business highlight: • Agreement with Blue Rhine General Trading for the distribution of SYNAPS 17

Questions & Answers